Diagnostic Molecular and Cytogenetic Findings in Sarcomas | |||
Histologic Type | Translocation or Rearrangement | Fusion Gene or Other Feature | |
Alveolar soft part sarcoma | t(X;17)(p11;q25) | ASPL-TFE3 | |
Angiomatoid fibrous histiocytoma | t(12;22)(q13;q12) | EWSR1-ATF1 | |
t(12;16)(q13;p11) | FUS-ATF1 | ||
t (2;22)(q33;q12) | EWSR1-CREB1 | ||
Clear cell sarcoma of soft parts | t(12;22)(q13;q12) | EWSR1-ATF1 | |
Clear cell sarcoma (gastrointestinal) | t(2;22)(q33;q12) | EWSR1-CREB1 | |
Dermatofibrosarcoma protuberans and variants | t(17;22)(q21;q13) | COL1A1-PDGFB | |
Ring form of chromosomes 17 and 22 | |||
Desmoplastic small round cell tumor | t(11;22)(p13;q12) | EWSR1-WT1 | |
t(21;22)(q22;q12) | EWSR1-ERG | ||
Endometrial stroma sarcoma | t(7;17)(p15:q21) | JAZF1-JJAZ1 | |
t(6;7)(p21;p22) | JAZF1-PHF1 | ||
t(10:17)(q22;p13) | |||
Epithelioid hemangioendothelioma | t(1;3)(p36.3;q25) | ||
t(10;14)(p13;q24) | Gene for VEGF-related protein at 14q24 | ||
Epithelioid sarcoma | Abnormalities of 22q | INI1 inactivation | |
Ewing sarcoma/primitive neuroectodermal tumor | t(11;22)(q24;q12) | EWSR1-FLI1 | |
t(21;22)(q12;q12) | EWSR1-ERG | ||
t(2;22)(q33;q12) | EWSR1-FEV | ||
t(7;22)(p22;q12) | EWSR1-ETV1 | ||
t(17;22)(q12;q12) | EWSR1-E1AF | ||
inv(22)(q12;q12) | EWSR1-ZSG | ||
Extraskeletal myxoid chondrosarcoma | t(9;22)(q22;q12) | EWSR1-NR4A3 | |
t(9;17)(q22;q11) | TAF1168-NR4A3 | ||
t(9;15)(q22;q21) | TCF12-NR4A3 | ||
Fibrosarcoma, infantile | t(12;15)(p13;q26) | ETV6-NTRK3 | |
Trisomies 8, 11, 17, and 20 | |||
Gastrointestinal stromal tumor | KIT, PDGFRA mutations | ||
Inflammatory myofibroblastic tumor | 2p23 rearrangement | ALK fusions with various genes | |
Leiomyosarcoma | Deletion of 1p | ||
Liposarcoma | |||
Well-differentiated | Ring form of chromosome 12 | 12q13-15 amplicon including MDM2, CDK4, HMGA2 | |
Dedifferentiated | Ring forms and complex changes | 12q14 amplicon including MDM2, CDK4, HMGA2, ASK1, and JUN amplification | |
Spindle cell | RB1 deletion | ||
Myxoid/round cell | t(12;16)(q13;p11), t(12;22)(q13;q12) | FUS-DDIT3 | |
t(12;22)(q13;q12) | EWSR1-DDIT3 | ||
Pleomorphic | Complex changes, multiple karyotypes | ||
Low-grade fibromyxoid sarcoma | t(7;16)(q33;p11) | FUS-CREB3L2 | |
FUS-CREB3L1 (in a small number of cases) | |||
Malignant rhabdoid tumor | Deletion of 22q | INI1 inactivation | |
Malignant peripheral nerve sheath tumor | Complex changes | NF1 inactivation, INK4A deletion | |
Myxofibrosarcoma | Ring form of chromosome 12, complex changes | ||
Myoxinflammatory fibroblastic sarcoma | t(1;10)(p22;q24), t(2;6)(q31;p21.3) | ||
Rhabdomyosarcoma | |||
Embryonal | Trisomies 2q, 8, and 20 | Loss of heterozygosity at 11p15 | |
Alveolar | t(1;13)(p36;q14) | PAX7-FKHR | |
t(2;13)(q35;q14) | PAX3-FKHR | ||
Synovial sarcoma | t(X;18)(p11;q11) | SS18-SSX1, SS18-SSX2 | |
SS18-SSX4 (very rarely) | |||
t(X;20)(p11;q13) | SS18L1-SSX1 |
Translocations and Other Genetic Anomalies in Sarcomas
Translocations and Other Genetic Anomalies in Sarcomas
Cyril Fisher, MD, DSc, FRCPath